Sales of Celgene’s marquee cancer drug are growing despite questions about how the Trump administration’s plan to address rising drug costs will affect pharmacy companies.
[Trump speech on drug prices set for May 11, sources say]
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.